… -- objective measures of disease -- that will enable early and accurate diagnosis and allow to track disease progression and … with at least two fMRI scans in the PPMI dataset. Impact on Diagnosis/Treatment of Parkinson's disease: With the resting … Research Grant …

… need to identify measurements that reflect how people with early PD function and feel. The Critical Path (C-Path) … agencies to optimize patient-centric measures for use in early PD trials. The staff at C-Path include clinical … all trial stages for early PD populations. Impact on Diagnosis/Treatment of Parkinson’s disease: The project will …

… validity of the CDR-SOB by comparing the scale to expert diagnosis in a cohort of 100 participants with PD at the … will demonstrate good criterion (compared with expert diagnosis) and convergent (compared with commonly-used … PD-MCI as an acceptable outcome measure will accelerate research to identify treatments for PD-MCI. Next Steps for …

… This grant builds upon the research from a prior grant: Combining Mass Spectrometry … of disease activity) for use in point-of-care assays for early detection and prognosis, as well as pharmacodynamic … biochemical and functional validation studies. Impact on Diagnosis/Treatment of Parkinson's Disease: There are …

… recruit 100 people in different stages of PD, from minimal early symptoms to advanced disease. All participants in the … PD examinations and questionnaires at each visit. Impact on Diagnosis/Treatment of Parkinson’s disease:  At present, … phosphorylated alpha-synuclein, translating the results into clinical practice and supporting biopharmaceutical drug …

… Disease (PD) patients through routine assays. Clinical research on PD suggests that the aggregation (clumping) of … invention of so-called super-resolution microscopes in the early 2000’s. We have long been involved in this process, … can be used reliably as a diagnostic. Relevance to Diagnosis/Treatment of Parkinson’s …